BCCA Protocol Summary for Adjuvant Therapy for Breast Cancer
1 févr. 2014 BC Cancer Agency Protocol Summary BRAJAC. Page 1 of 2 ... using DOXOrubicin and Cyclophosphamide. Protocol Code. BRAJAC. Tumour Group.
BRAJAC Protocol
BCCA Protocol Summary for Treatment of Thymoma with Platinum
1 févr. 2012 BCCA Protocol Summary for Treatment of Advanced Salivary. Gland Cancers with Platinum. DOXOrubicin
HNSAVPAC Protocol
DRUG NAME: Cyclophosphamide
1 juin 2013 BC Cancer Agency Breast Tumour Group. BCCA Protocol summary for adjuvant therapy for breast cancer using cyclophosphamide doxorubicin and ...
Cyclophosphamide monograph June formatted
DRUG NAME: Doxorubicin
BC Cancer Agency Sarcoma Tumour Group. BCCA Protocol summary for Adjuvant Therapy for vincristine adriamycin and cyclophosphamide with Newly Diagnosed Ewing's
Doxorubicin monograph
BCCA Protocol Summary for Palliative Therapy for Advanced
1 févr. 2014 BCCA Administration Guideline. DOXOrubicin. (ADRIAMYCIN®). 50 mg/m². IV push fluorouracil (5-FU) 500 mg/m². IV push cyclophosphamide 500 ...
HNSAVFAC Protocol
BCCA Protocol Summary for Palliative Therapy for Metastatic Breast
1 févr. 2014 BC Cancer Agency Protocol Summary BRAVAC. Page 1 of 2 ... Cancer using DOXOrubicin and Cyclophosphamide. Protocol Code: BRAVAC.
BRAVAC Protocol
BC Cancer Protocol Summary for Neoadjuvant or Adjuvant Therapy
For the 4 cycles of DOXOrubicin and cyclophosphamide: Antiemetic protocol for highly emetogenic chemotherapy (see protocol SCNAUSEA).
BRAJACTTG Protocol
BC Cancer Protocol Summary for Treatment of Lymphoma with
DOXOrubicin Cyclophosphamide
LYCHOPR Protocol
BC Cancer Protocol Summary for Neoadjuvant or Adjuvant Therapy
for Early Breast Cancer Using DOXOrubicin and Cyclophosphamide followed by Weekly PACLitaxel. Protocol Code: BRAJACTW. Tumour Group:.
BRAJACTW Protocol
BC Cancer Protocol Summary for Treatment of Locally Advanced
Breast Cancer using Doxorubicin and Cyclophosphamide followed by. DOCEtaxel. Protocol Code. BRLAACD. Tumour Group. Breast. Contact Physician.
BRLAACD Protocol
- doxorubicin cyclophosphamide bcca